Equity Analysis

Analyst Poll - Detailed News
Bank of Baroda
24-Jan-20   21:22 Hrs IST
Bank of Baroda conducted an analyst meet on 24 January 2020 to discuss the financial results for the quarter ended December 2019 and prospects of the bank. Sanjiv Chadha, MD&CEO of the bank addressed the meet:

Highlights:

- The bank has witnessed higher operating expenses in Q3FY2020 on account of expenses related to ESPS.

- The fresh slippages of loans increased to 10387 crore in Q3FY2020, of which Rs 4509 crore were related to NPA divergence as per RBI supervision report. The NPA divergence was mainly on account of shortfall in provisions after decline in the security value relating to 3-4 accounts which include 1 chemical account and 2 road projects, while these accounts are making interest payments.

- The chemical sector account has exposure of Rs 2700 crore, while two power sector accounts has exposure of Rs 1000 crore.

- The three accounts from NBFC sector (Rs 2000 crore) were among major accounts contributing to fresh slippages in Q3FY2020. Slippages from agriculture sector stood at Rs 522 crore, MSME at Rs 1000 crore, retail at Rs 450 crore, corporate at Rs 5100 crore and international business Rs 3300 crore.

- The bank has witnessed increase in Gross NPAs in the international business from Rs 7623 crore to Rs 10530 crore on sequential basis due to divergence.

- The watchlist of stressed account has declined to Rs 10500 crore end December 2019 from Rs 14000 crore end September 2019. About 85% of the fresh slippages in the quarter ended December 2019 came from the watchlist accounts end September 2019.

- Bank expects recoveries to come in from 2-3 big accounts in Q4FY2020.

- The bank holds 20% provisioning on Reliance Home Finance account

- The bank has provided the benefit of MSME dispensation and restructured loans of Rs 1300 crore.

- The bank is targeting loan growth of 4-5% for FY20.

- The bank has expects of Rs 2000 crore which is classified as NPA in Q3FY2020, while making 20% provision

- The bank has improved NIM yoy driven by decline in cost of funds.

- PCR continues to be high at 77.8% end December 2019. The bank has strong 89% PCR on NCLT exposure.

- CRAR comfortable at 13.48% end December 2019

- SMA 2 has declined to 1.54% end December 2019.

Powered by Capital Market - Live News